- Report
- August 2022
- 120 Pages
Global
From €4013EUR$4,500USD£3,480GBP
- Report
- August 2022
- 120 Pages
Global
From €4013EUR$4,500USD£3,480GBP
- Report
- August 2022
- 115 Pages
Global
From €4013EUR$4,500USD£3,480GBP
- Report
- August 2022
- 102 Pages
Global
From €4013EUR$4,500USD£3,480GBP
- Report
- May 2024
- 176 Pages
Global
From €2229EUR$2,500USD£1,934GBP
- Report
- December 2024
- 200 Pages
Global
From €3344EUR$3,750USD£2,900GBP
- Report
- October 2024
- 200 Pages
Global
From €3344EUR$3,750USD£2,900GBP
- Report
- October 2024
- 200 Pages
Global
From €3344EUR$3,750USD£2,900GBP
- Report
- May 2024
- 200 Pages
Global
From €3701EUR$4,150USD£3,210GBP
- Report
- March 2024
- 200 Pages
Global
From €3701EUR$4,150USD£3,210GBP
- Report
- March 2024
- 200 Pages
Global
From €3701EUR$4,150USD£3,210GBP
- Report
- March 2024
- 200 Pages
Global
From €3701EUR$4,150USD£3,210GBP
- Report
- March 2024
- 200 Pages
Global
From €3701EUR$4,150USD£3,210GBP
- Report
- October 2023
- 145 Pages
Global
From €2809EUR$3,150USD£2,436GBP
- Report
- January 2025
- 175 Pages
Global
From €4004EUR$4,490USD£3,473GBP
- Report
- January 2025
- 175 Pages
Global
From €4004EUR$4,490USD£3,473GBP
- Report
- January 2025
- 175 Pages
Global
From €4004EUR$4,490USD£3,473GBP
- Report
- January 2025
- 175 Pages
Global
From €4004EUR$4,490USD£3,473GBP
- Report
- February 2023
- 175 Pages
Global
From €4459EUR$5,000USD£3,867GBP
- Report
- December 2024
- 66 Pages
Global
From €3522EUR$3,950USD£3,055GBP

The Gastrointestinal Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat diseases and disorders of the gastrointestinal tract. These drugs are used to treat conditions such as irritable bowel syndrome, Crohn's disease, ulcerative colitis, and gastroesophageal reflux disease. Commonly prescribed drugs include antacids, proton pump inhibitors, and H2 receptor antagonists.
The Gastrointestinal Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Pfizer, GlaxoSmithKline, Merck & Co., AstraZeneca, and Novartis. These companies are constantly developing new drugs and treatments to meet the needs of patients. Show Less Read more